In order to further understand the role of PARP1, XRCC4 and ERCC1 in predicting the prognosis, metastasis of breast cancer, we also studied the best cut-off value of PARP1, XRCC4 and ERCC1. This evidence concerns the gene PARP1 and breast carcinoma.